Not checkedNot checked for notices yet.
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fatma H. EL Nouby, Nihal Ahmed Fathi, Amal Abdelaziz Fehr and 3 more
Egyptian Rheumatology and Rehabilitation · 2020
doi:10.1186/s43166-020-00028-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background Intolerance to MTX is the most common cause of non-compliance that leads to poor disease control. Treatment is usually discontinued due to intolerance which interferes with compliance of the patient to long-term treatment. Caffeine causes most of its biological effects via antagonizing all types of adenosine receptors (ARs). Our aim was to investigate the effect of caffeine intake on reducing symptoms of MTX intolerance in patients with RA. Methods Ninety patients were diagnosed as RA with MTX intolerance divided into 2 groups. Sixty patients were prescribed caffeine or dark chocolate. Control group included 30 patients who will continue MTX regimen without addition of any extra caffeine. Results Group A (caffeine group): There was no statistically significant difference between patients and controls at the start of the study. There was statistically significant decrease in methotrexate intolerance severity score (MISS) all over the study period ( P = 0.001), and also MISS was statistically significantly lower in each follow-up time when compared with time 0 ( P = 0.001). Group B (control group): There was statistically significant increase in MISS all over the study period ( P = 0.017); also, MISS was statistically significantly higher in follow-up time 2 and time 3 when compared with time 0 ( P = 0.033). We found that after 3 months, 80% of group A patients showed complete relief, 6.7% showed partial relief, 10% showed minimal relief, and 3.3% got worse. Conclusion Adding caffeine to management regimen can reduce the symptoms of MTX intolerance in RA patients. Caffeine relieved the symptoms of MTX intolerance in 80% of RA patients after 3 months of adding caffeine to management regimen.
Abstract licence: CC BY-NC-ND
References16
16 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.